Formulation of aqueous injection of carbamazepine
Jain, N.K.; Agrawal, R.K.; Singhai, A.K.
Die Pharmazie 45(3): 221-222
1990
ISSN/ISBN: 0031-7144 PMID: 2381970 Document Number: 351768
Document emailed within 1 workday
Related Documents
2003: Paracetamol for injection: new formulation. New formulation: why so widely used? Prescrire International 12(67): 178Ullah, M.; Shah, M.R.; Bin Asad, M.H.H.; Hasan, S.M.F.; Hussain, I. 2017: Improved in vitro and in vivo performance of carbamazepine enabled by using a succinic acid cocrystal in a stable suspension formulation Pakistan Journal of Pharmaceutical Sciences 30(6): 2139-2145
Degen, J.; Wölke, E.; Seiberling, M.; Thomann, P.; Völter-Erhardt, H. 1997: Comparison of the relative bioavailability and pharmacokinetics of estrone after oral administration of esterified estrogens in a tablet formulation and an aqueous suspension Arzneimittel-Forschung 47(2): 208-212
Nahata, M.C.; Roberts, D.L. 1987: Formulation of caffeine injection for I.v. administration American Journal of Hospital Pharmacy 44(6): 1308; 1312
Keough, G.C.; English, J.C.; Meffert, J.J. 1998: Eczematous hypersensitivity from aqueous vitamin K injection Cutis 61(2): 81-83
Guo, Y.; Chen, X.; Zhao, Y.; Sun, J. 1996: Screening for the new formulation of 25% ascorbic acid injection and studies on its stability Hua Xi Yi Ke da Xue Xue Bao 27(3): 327-331
Tenner, A.; Jaeger, W.; Koch, W. 1974: Demonstration of aqueous veins through injection of fluorescein into the anterior chamber in rabbits Klinische Monatsblatter für Augenheilkunde 164(5): 628-632
Dugué, J.; Céolin, R.; Rouland, J.C.; Lepage, F. 1991: Polymorphism of carbamazepine: solid-state studies on carbamazepine dihydrate Pharmaceutica Acta Helvetiae 66(11): 307-310
Amore, B.M.; Kalhorn, T.F.; Skiles, G.L.; Hunter, A.P.; Bennett, G.D.; Finnell, R.H.; Nelson, S.D.; Slattery, J.T. 1997: Characterization of carbamazepine metabolism in a mouse model of carbamazepine teratogenicity Drug Metabolism and Disposition: the Biological Fate of Chemicals 25(8): 953-962
Hydzik, P.; Balicka-Slusarczyk, B.; Jastrzebski, M. 2011: Cardiologic interaction carbamazepine with atypical neuroleptics. Acute mixed carbamazepine and quetiapine intoxication--case report Przeglad Lekarski 68(8): 499-502
Montoya-Cabrera, M.A.; Sauceda-García, J.M.; Escalante-Galindo, P.; Flores-Alvarez, E.; Ruiz-Gómez, A. 1996: Carbamazepine poisoning in adolescent suicide attempters. Effectiveness of multiple-dose activated charcoal in enhancing carbamazepine elimination Archives of Medical Research 27(4): 485-489
Ono, M.; Shimamine, M.; Takahashi, K. 1971: The application of non-aqueous titration procedure to medicinal narcotic drugs. 3. Determination of papaverine hydrochloride in opium alkaloids hydrochlorides, atropine and papaverine injection Eisei Shikenjo Hokoku. Bulletin of National Institute of Hygienic Sciences 89: 81-82
Krichevskaya, M.; Malygina, T.; Preis, S.; Kallas, J. 2001: Photocatalytical oxidation of de-icing agents in aqueous solutions and aqueous extract of jet fuel Water Science and Technology: a Journal of the International Association on Water Pollution Research 44(5): 1-6
2003: Sublingual selegiline: new formulation. New formulation: new risk of oral adverse effects Prescrire International 12(67): 179
2002: Tobramycin for nebulisation: new formulation. A high price for a small improvement in formulation Prescrire International 11(62): 177-178
Wang, Y.J.; Leesman, G.D.; Lipstein, M.E.; Basch, H.I.; Monkhouse, D.C. 1984: Optimization of autoclave cycles and selection of formulation for parenteral products, Part III: Effect of formulation variables on sporicidal kinetics Journal of parenteral science and technology: a publication of the Parenteral Drug Association 38(2): 78-82
Soni, S.D.; Tench, D.; Ashwood, T.J.; Movin, G. 1990: Pharmacokinetics of an oral controlled release formulation of remoxipride: a double-blind, crossover comparison with conventional formulation in chronic schizophrenics Acta Psychiatrica Scandinavica. Supplementum 358: 45-47
Sofia, C.; Portela, F.; Gregório, C.; Rosa, A.; Camacho, E.; Tomé, L.; Ferreira, M.; Andrade, P.; Cabral, P.; Romãozinho, J.; Gouveia, H.; Leitão, M.; Pimenta, I.; Donato, A.; Freitas, D. 2000: Endoscopic injection therapy vs. multipolar electrocoagulation vs. laser vs. injection + octreotide vs. injection + omeprazole in the treatment of bleeding peptic ulcers. A prospective randomized study Hepato-Gastroenterology 47(35): 1332-1336
Vens-Cappell, B.; Hilgenstock, C.; Gellert, M.; Kühle, K.; Reifferscheid, I.; Winckler, P.; Bührens, K.G. 1993: Comparison of the pharmacokinetics of a quick-release bezafibrate formulation with a sustained-release formulation. 1. Single-dose administration Arzneimittel-Forschung 43(3): 346-350
Jehl, F.; Klossek, J.M.; Peynegre, R.; Serrano, E.; Castillo, L.; Bobin, S.; Desprez, D.; Renault, C.; Neel, V.; Rouffiac, E.; Borie, C. 2002: Sinusal penetration of amoxicillin-clavulanic acid. Formulation 1 g./125 mg., twice daily versus formulation 500 mg./125 mg., three times daily Presse Medicale 31(34): 1596-1603